Trial · NCT03033745
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Responders | IgPro20 (Pump-Assisted Volume Cohort) | 25 ml | 86.7 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump-Assisted Volume Cohort) | 40 ml | 73.3 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump-Assisted Volume Cohort) | 50 ml | 73.3 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump Assisted Flow Rate Cohort) | 25 ml/h | 77.8 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump Assisted Flow Rate Cohort) | 50 ml/h | 77.8 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump Assisted Flow Rate Cohort) | 75 ml/h | 66.7 | percentage of responders | |
| Percentage of Responders | IgPro20 (Pump Assisted Flow Rate Cohort) | 100 ml/h | 61.1 | percentage of responders | |
| Percentage of Responders | IgPro20 (Manual Push Flow Rate Cohort) | 30 ml/h | 100.0 | percentage of responders | |
| Percentage of Responders | IgPro20 (Manual Push Flow Rate Cohort) | 60 ml/h | 100.0 | percentage of responders | |
| Percentage of Responders | IgPro20 (Manual Push Flow Rate Cohort) | 120 ml/h | 87.5 | percentage of responders | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump-Assisted Volume Cohort) | 25 ml | 0.183 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump-Assisted Volume Cohort) | 40 ml | 0.188 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump-Assisted Volume Cohort) | 50 ml | 0.023 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump Assisted Flow Rate Cohort) | 25 ml/h | 0.329 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump Assisted Flow Rate Cohort) | 50 ml/h | 0.255 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump Assisted Flow Rate Cohort) | 75 ml/h | 0.140 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Pump Assisted Flow Rate Cohort) | 100 ml/h | 0.085 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Manual Push Flow Rate Cohort) | 30 ml/h | 0.064 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Manual Push Flow Rate Cohort) | 60 ml/h | 0.111 | Number of TEAEs/infusion | |
| Rate of Treatment-emergent Adverse Events (TEAEs) Per Infusion | IgPro20 (Manual Push Flow Rate Cohort) | 120 ml/h | 0.081 | Number of TEAEs/infusion |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03033745/results